NEW YOR, NY – October 11, 2012 - - Vringo, Inc.(AMEX:VRNG) shares increased 4.07% to $4.86. Attorneys from Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. represented Vringo, Inc., in the direct offering of 10.3 million shares of its common stock. The company's gross proceeds from the transaction totaled $46 million.
Additionally, the company said its wholly-owned unit, Vringo Infrastructure, Inc., filed a lawsuit in the UK High Court of Justice against the UK subsidiary of ZTE Corp., alleging infringement over handsets, base stations and base station controllers.
Will VRNG Move Higher After Today’s Sudden Selling Activities? Don’t Miss The Free Trend Analysis here http://beststocksdaily.com/p2/index.php?company=VRNG
Advanced Cell Technology, Inc.(OTC:ACTC) stock gained 2.03% to $0.0752. The company announced that the Data and Safety Monitoring Board (DSMB), an independent group of medical experts closely monitoring the Company’s three ongoing clinical trials, has authorized the Company to move forward with enrollment and treatment of second and third additional patients with Stargardt’s macular dystrophy (SMD) in the second patient cohort of its U.S. trial for the condition. Additionally, the DSMB has authorized the Company to treat all three patients in the second cohort of its European trial for SMD.
How Should Investors Trade ACTC After The Recent Momentum, Find Out Here http://beststocksdaily.com/p2/index.php?company=ACTC
AMARANTUS BIOSCIENCES INC(OTC:AMBS) shares climbed 10.17% to $0.0065 in the early hour. The company provided an update to shareholders from its President & CEO Gerald E. Commissiong. "The fundamental progress the Company has made since our First Annual CEO Letter was released in May has been quite significant. The company have achieved: Positive animal proof-of concept data for MANF in the multi-billion dollar Myocardial Infarction market; Secured the license for the NuroPro Parkinson's diagnostic blood test; and Successfully concluded our research collaboration with Banyan Biomarkers, showing positive proof-of concept data for MANF in Traumatic Brain Injury.
Get Free Special Trend Analysis On AMBS Here http://beststocksdaily.com/p2/index.php?company=AMBS
MEDIA SENTIMENT INC(PINK:MSEZ) stock is trading at $0.0001 in the early hour. The company, last month, said that it is in the final stages of finalizing the acquisition of a new asset, namely the social media video curation technology of videocourier.com.
MSEZ said it will continue its search for additional acquisition candidates, and foresees closing this transaction within the next 3 to 5 business days.
Get Free Special Trend Analysis On MSEZ Here http://beststocksdaily.com/p2/index.php?company=MSEZ
Converted Organics Inc.(PINK:COIN) stock dropped 10% to $0.0009 in the early hour. The 52 week trading range for the company is $0.00 - $250.00. The shares of the company plunged 91% in the last one year. The company utilize clean technologies to establish and operate environmentally friendly businesses. Converted Organics operates in three segments: Organic Fertilizer, Industrial Wastewater Treatment and Vertical Farming.
Get Free Special Trend Analysis On COIN Here http://beststocksdaily.com/p2/index.php?company=COIN
Beststocksdaily’s team is engaged in providing valuable and updated news information on U.S. stocks on a regular basis. Beststocksdaily’s instant stock news on Major Gainers, Hot Stocks and various other stocks, guides investors in making the wise stock market investments decision. To Get Instant updates in the inbox, readers are advised to sign up for free at Beststocksdaily.com.
The assembled information disseminated by beststocksdaily.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. beststocksdaily.com does expect that investors will buy and sell securities based on information assembled and presented in beststocksdaily.com. PLEASE always do your own due diligence, and consult your financial advisor.
1419 Westwood Blvd Los Angeles, CA